The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
RockyKanaka on MSN
Runny Nose in Dogs: 7 Reasons You Shouldn’t Ignore It
Runny noses and snot are not typically associated with dogs. But, dogs can get runny noses but for very different reasons. Find out why.
The EVEREST trial directly compared biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma, and found that dupilumab (Dupixent) was superior to omalizumab (Xolair) ...
No one enjoys having a runny nose—and that includes your dog! Just like humans, dogs can develop runny noses for a variety of reasons. Before you worry, make sure it’s truly a runny nose. A dog’s nose ...
The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma showed an advantage to dupilumab (Dupixent) over ...
Amgen (AMGN) and AstraZeneca (AZN) are approaching a potential catalyst event on October 19, when the FDA will rule on Tezspire for treating chronic rhinosinusitis with nasal polyps (CRSwNP). If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback